Sandro Sorbi Selected Research

Alzheimer Disease (Alzheimer's Disease)

03/2008	Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
01/2008	Cathepsin D expression is decreased in Alzheimer's disease fibroblasts.
09/2007	Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.
09/2007	Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
07/2007	Association studies between the plasmin genes and late-onset Alzheimer's disease.
05/2007	Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
04/2007	Testing for linkage and association across the dihydrolipoyl dehydrogenase gene region with Alzheimer's disease in three sample populations.
02/2007	The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.
01/2007	Pattern and Progression of Cognitive Decline in Alzheimer's Disease: Role of Premorbid Intelligence and ApoE Genotype.
11/2006	Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
06/2006	Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
05/2006	Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
01/2006	Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
11/2005	Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
10/2005	Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease.
02/2005	The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease.
09/2004	Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
03/2004	Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.
03/2004	Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy.
02/2004	Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
11/2003	Identification of new presenilin gene mutations in early-onset familial Alzheimer disease.
10/2003	Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation.
08/2002	Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease.
07/2002	Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease.
05/2002	Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease.

Articles by Research Topic

Disease

25	Alzheimer Disease (Alzheimer's Disease) 03/2008 - 05/2002
2	Eating Disorders (Eating Disorder) 05/2008 - 04/2002
2	Multiple Sclerosis 03/2008 - 08/2002
2	Anorexia 04/2006 - 06/2004
2	Bulimia Nervosa (Binge Eating Disorder) 04/2006 - 07/2004
2	Anorexia Nervosa 04/2005 - 07/2004
1	Huntington Disease (Huntington's Disease) 09/2008
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 08/2008
1	Dementia (Dementias) 03/2008
1	Ulcerative Colitis 01/2008
1	Parkinson Disease (Parkinson's Disease) 10/2007
1	Atherosclerosis (Atheroma) 01/2007
1	Stroke (Strokes) 01/2007
1	Bulimia (Binge Eating) 06/2004
1	Weight Loss (Weight Reduction) 06/2004
1	Relapsing-Remitting Multiple Sclerosis 04/2004

Drug/Important Bio-Agent (IBA)

4	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2005 - 03/2004
3	Apolipoproteins E (ApoE)IBA 01/2007 - 02/2004
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2008 - 03/2004
2	Interleukin-10 (Interleukin 10)IBA 01/2008 - 05/2007
2	Cathepsin DIBA 01/2008 - 08/2002
2	PresenilinsIBA 06/2006 - 11/2003
2	ApolipoproteinsIBA 09/2004 - 04/2004
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 07/2004 - 04/2002
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2008
1	AntibodiesIBA 08/2008
1	Nerve Growth Factor (NGF)IBA 05/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2008
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2007
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2007
1	Plasmin (Fibrinolysin)FDA Link 07/2007
1	Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA 04/2007
1	sortilinIBA 02/2007
1	Heparin (Liquaemin)FDA LinkGeneric 01/2007
1	Aryldialkylphosphatase (Paraoxonase)IBA 11/2006
1	CalciumIBA 06/2006
1	cholesterol 24-hydroxylase (CYP46)IBA 05/2006
1	GhrelinIBA 04/2006
1	Glucose (Dextrose)FDA LinkGeneric 11/2005
1	Insulysin (Insulin-Degrading Enzyme)IBA 10/2005
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2005
1	Glycoside Hydrolases (Endoglycosidases)IBA 10/2003
1	CD45 Antigens (CD45 Antigen)IBA 08/2002
1	Prostaglandins E (PGE)IBA 07/2002
1	serotonin 6 receptorIBA 05/2002

Therapy/Procedure

1	Transplantation (Transplant Recipients) 09/2008
1	Deep Brain Stimulation 10/2007